Search Results - "THRASHER, A"

Refine Results
  1. 1
  2. 2
  3. 3

    The Wiskott-Aldrich syndrome by Ochs, Hans D., Thrasher, Adrian J.

    Published in Journal of Allergy and Clinical Immunology (01-04-2006)
    “…The Wiskott-Aldrich syndrome (WAS) is a rare X-linked disorder with variable clinical phenotypes that correlate with the type of mutations in the WAS protein (…”
    Get full text
    Journal Article
  4. 4

    The Effects of Coding Schemes on Vibrotactile Biofeedback for Dynamic Balance Training in Parkinson's Disease and Healthy Elderly Individuals by Lee, Beom-Chan, Fung, Alberto, Thrasher, Timothy A.

    “…Coding scheme for earlier versions of vibrotactile biofeedback systems for balance-related applications was primarily binary in nature, either on or off at a…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Special Article: Chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry by Jones, L.B.K.R, McGrogan, P, Flood, T.J, Gennery, A.R, Morton, L, Thrasher, A, Goldblatt, D, Parker, L, Cant, A.J

    Published in Clinical and experimental immunology (01-05-2008)
    “…There are no epidemiological studies from the British Isles of chronic granulomatous disease, characterized by recurrent, life-threatening bacterial and fungal…”
    Get full text
    Journal Article
  7. 7

    Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients by CHARRIER, S, DUPRE, L, RONCAROLO, M. Grazia, GALY, A, SCARAMUZZA, S, JEANSON-LEH, L, BLUNDELL, M. P, DANOS, O, CATTANEO, F, AIUTI, A, ECKENBERG, R, THRASHER, A. J

    Published in Gene therapy (01-03-2007)
    “…Gene therapy has been proposed as a potential treatment for Wiskott-Aldrich syndrome (WAS), a severe primary immune deficiency characterized by multiple…”
    Get full text
    Journal Article
  8. 8

    A Synchronous Spin-Exchange Optically Pumped NMR-Gyroscope by Sorensen, Susan S., Thrasher, Daniel A., Walker, Thad G.

    Published in Applied sciences (01-10-2020)
    “…Inertial navigation systems generally consist of timing, acceleration, and orientation measurement units. Although much progress has been made towards…”
    Get full text
    Journal Article
  9. 9

    Progress and prospects: gene therapy for inherited immunodeficiencies by Qasim, W, Gaspar, H B, Thrasher, A J

    Published in Gene therapy (01-11-2009)
    “…Haematopoietic stem cell transplantation (HSCT) is now widely used to treat primary immunodeficiencies (PID). For patients with specific disorders (severe…”
    Get full text
    Journal Article
  10. 10

    Translational Mini‐Review Series on Immunodeficiency:
Molecular defects in common variable immunodeficiency by Bacchelli, C., Buckridge, S., Thrasher, A. J., Gaspar, H. B.

    Published in Clinical and experimental immunology (01-09-2007)
    “…Summary Common variable immunodeficiency (CVID) is a primary immunodeficiency that typically affects adults and is characterized by abnormalities of quantative…”
    Get full text
    Journal Article
  11. 11

    Current progress on gene therapy for primary immunodeficiencies by Zhang, L, Thrasher, A J, Gaspar, H B

    Published in Gene therapy (01-10-2013)
    “…Primary immunodeficiencies have played a major role in the development of gene therapy for monogenic diseases of the bone marrow. The last decade has seen…”
    Get full text
    Journal Article
  12. 12

    Progress and Prospects: Gene Therapy Clinical Trials (Part 1) by ALTON, Eric, BAINBRIDGE, J. W, GREZ, M, THRASHER, A. Z, OTT, M. G, SEGER, R, ALEXANDER, B. L, KAPLITT, M. G, SIMONS, M, YLÄ-HERTTUALA, S, ALL, R. R, GRIESENBACH, U, ALTON, E. W. F. W, FLOTTE, T. R, BRAUN, S, CHENG, S. H, THRASHER, A. J, GASPAR, H. B

    Published in Gene therapy (01-10-2007)
    “…Over the last two decades gene therapy has moved from preclinical to clinical studies for many diseases ranging from single gene disorders such as cystic…”
    Get full text
    Journal Article
  13. 13

    Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer by Pike-Overzet, K, Rodijk, M, Ng, Y-Y, Baert, M R M, Lagresle-Peyrou, C, Schambach, A, Zhang, F, Hoeben, R C, Hacein-Bey-Abina, S, Lankester, A C, Bredius, R G M, Driessen, G J A, Thrasher, A J, Baum, C, Cavazzana-Calvo, M, van Dongen, J J M, Staal, F J T

    Published in Leukemia (01-09-2011)
    “…Severe combined immunodeficiency (SCID) patients with an inactivating mutation in recombination activation gene 1 ( RAG1 ) lack B and T cells due to the…”
    Get full text
    Journal Article
  14. 14

    Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS by Zanta-Boussif, M A, Charrier, S, Brice-Ouzet, A, Martin, S, Opolon, P, Thrasher, A J, Hope, T J, Galy, A

    Published in Gene therapy (01-05-2009)
    “…The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) is widely used in retroviral gene transfer vectors. However, this element contains…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection by van der Loo, J C M, Swaney, W P, Grassman, E, Terwilliger, A, Higashimoto, T, Schambach, A, Baum, C, Thrasher, A J, Williams, D A, Nordling, D L, Reeves, L, Malik, P

    Published in Gene therapy (01-03-2012)
    “…The need for γ-retroviral (gRV) vectors with a self-inactivating (SIN) design for clinical application has prompted a shift in methodology of vector…”
    Get full text
    Journal Article
  17. 17

    Microbial Characterization during the Early Habitation of the International Space Station by Castro, V. A., Thrasher, A. N., Healy, M., Ott, C. M., Pierson, D. L.

    Published in Microbial ecology (01-02-2004)
    “…An evaluation of the microbiota from air, water, and surface samples provided a baseline of microbial characterization onboard the International Space Station…”
    Get full text
    Journal Article
  18. 18

    Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1 by BAINBRIDGE, J. W. B, MISTRY, A, DE ALWIS, M, PALEOLOG, E, BAKER, A, THRASHER, A. J, ALI, R. R

    Published in Gene therapy (01-03-2002)
    “…Retinal angiogenesis is a central feature of the leading causes of blindness. Current treatments for these conditions are of limited efficacy and cause…”
    Get full text
    Journal Article
  19. 19

    Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy by TSCHERNUTTER, M, SCHLICHTENBREDE, F. C, HOWE, S, BALAGGAN, K. S, MUNRO, P. M, BAINBRIDGE, J. W. B, THRASHER, A. J, SMITH, A. J, ALI, R. R

    Published in Gene therapy (01-04-2005)
    “…The Royal College of Surgeons (RCS) rat is a well-characterized model of autosomal recessive retinitis pigmentosa (RP) due to a defect in the retinal pigment…”
    Get full text
    Journal Article
  20. 20

    Neonatal dendritic cells are intrinsically biased against Th‐1 immune responses by LANGRISH, C. L., BUDDLE, J. C., THRASHER, A. J., GOLDBLATT, D.

    Published in Clinical and experimental immunology (01-04-2002)
    “…SUMMARY Dendritic cells (DCs) were derived from human peripheral blood monocytes or cord blood monocytes cultured in the presence of IL‐4 and GM‐CSF. Adult and…”
    Get full text
    Journal Article